The CFL2 gene gives muscle cells instructions for a protein that keeps their internal fibers in order. This gene helps your body produce smooth, controlled muscle contraction, so harmful variants can lead to muscle weakness, low muscle tone, and delayed movement skills, often from infancy or childhood. Some people with two nonworking copies have a congenital muscle condition called nemaline myopathy.
What is a gene?
Genes are sections of DNA that provide cells with instructions to make molecules or manage processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in LearnHub.
Overview
CFL2Gene function
What if the gene works
The CFL2 gene helps muscle cells organize and recycle actin, a protein that gives fibers shape and supports movement. This helps muscles develop normally and contract in a coordinated way.
Risk
What if the gene does not work
Different variants in the CFL2 gene can cause a muscle condition from birth, often with low muscle tone and weakness that affects movement; milder or more severe variants may lead to milder symptoms or breathing problems.
Treatment
What does that mean for your treatment
No gene-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the CFL2 gene. Care is symptom-based and may include physical therapy, mobility support, and monitoring for breathing or swallowing problems.
Conditions associated with CFL2
Gene function
What if the gene works
Muscle cells need constant upkeep to keep their inner scaffolding neat and responsive. The CFL2 gene supports this day to day by helping muscle fibers reshape key protein strands called actin. Understanding the CFL2 gene’s function in muscle cells helps explain how muscles keep their structure and move in a controlled way.
CFL2 helps muscle cells trim and recycle actin filaments, the tiny strands that support cell shape and movement. This keeps the cell’s inner framework flexible and ready for repeated use.
Its protein helps arrange actin within the parts of muscle fibers that generate force. This orderly layout supports smooth contraction during everyday movement.
Muscle tissue works again and again, so actin needs steady renewal. By supporting this routine upkeep, the CFL2 gene helps muscle fibers stay organized as they do their day to day work.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFL2 gene can alter how the cofilin-2 protein folds or how well it binds and reshapes actin filaments, which helps explain how CFL2 gene variants affect muscle cells. Some variants leave partial activity, but more severe variants can make the protein unstable, reduce its level, or block its activity almost completely. In people with CFL2 related muscle disease, this range in functional effect may shape how early symptoms appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in the CFL2 gene cause a rare inherited muscle condition called nemaline myopathy, often with muscle weakness that begins in infancy or childhood. In people with CFL2 gene variants and nemaline myopathy, day to day effects can include low muscle tone, delayed motor milestones, and trouble with walking, feeding, or breathing, although severity can vary. This is a confirmed gene-condition link rather than a general risk marker.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead represent part of natural human variation. For many genes, having a variant connected with a condition points to a possible association rather than a certain diagnosis, particularly when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CFL2-related muscle conditions, risk is mainly set by the gene changes inherited in a family rather than by lifestyle or everyday exposures. There is not yet broadly confirmed evidence that specific habits or environmental factors meaningfully increase or reduce this genetic risk.
Inheritance of CFL2 variants
CFL2 gene inheritance for the known CFL2-related muscle condition follows an autosomal recessive pattern. This means a child usually inherits one altered CFL2 gene copy from each parent, and parents who carry one copy typically do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of inheriting no altered copy.
What does my CFL2 result mean for my family?
Changes in the CFL2 gene are linked to a rare muscle condition that usually runs in families in a recessive way. For family members, this often means parents may be healthy carriers, and brothers or sisters could also be affected or be carriers. Other relatives may also carry the gene change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CFL2 variants uses a blood or saliva sample, usually through a muscle disease panel or exome sequencing. Results can show whether a variant in the CFL2 gene may explain muscle weakness and can also help clarify whether the same variant is present in relatives.
When should I consider getting a genetic test?
Genetic testing for the CFL2 gene may be considered when someone has unexplained muscle weakness starting in infancy, childhood, or early adult life, especially with delayed motor milestones or a family history of an inherited muscle condition. A CFL2 test can help confirm whether this rare muscle condition is the cause.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the type of variant. Over time, the way the body works is also shaped by many other influences, including lifestyle, the environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can also help place a person’s individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds at the drug’s target, so the same treatment may work better for one person than another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater depth, you can learn more in the LearnHub.
Drugs influenced by the CFL2 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dosing at this time, so any concerns about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor or pharmacist.